Information operations

Facebook held a special breakfast for drug marketers about recruiting people for clinical trials


  • Kay Nietfeld | AFP | Getty Images Facebook founder and chief Mark Zuckerberg receives the Axel Springer Award in Berlin on February 25, 2016 Facebook announced it was donating computer servers to a number of research institutions across Europe, starting with Germany, to accelerate research efforts in artificial intelligence (AI) and machine learning.

    Facebook brought drug marketers together to educate them on targeting consumers.

  • The company is going after an industry that’s rapidly increasing its digital ad spending.

Kay Nietfeld | AFP | Getty Images

Facebook’s ad sales team is hitting up the drug industry.

On Thursday, the company’s New York-based health unit hosted an invitation-only breakfast for pharmaceutical marketers to learn about targeting users for their clinical trials.

CNBC viewed a copy of the invitation, which asked participants to attend a presentation on the company’s “new clinical trials strategy.”

Facebook is already widely used by clinical trial recruiters. The sector is a massive revenue opportunity for the company. Research firm eMarketer estimates that pharma and health-care marketers will spend $3.1 billion on digital advertising by 2020, up from $1.9 billion last year.

According to a person who attended Thursday’s event, Facebook detailed how drug marketers can and can’t target users. The source requested anonymity because Facebook did not make the details public.

Facebook’s health team explained that users can’t be targeted based on health conditions like insomnia. This is not limited to clinical trials.

Marketers can target people by demographics and their expressed interests, or likes. Millions of health groups have organically popped up on Facebook for people with a variety of health conditions, though marketers can’t use that data in their outreach.

Some drug companies have been reluctant to use Facebook due to concerns that patients will share sensitive information like medical side effects and adverse events. Pharmaceutical companies are required to monitor and report these comments.

This wasn’t Facebook’s first event for drug marketers. CNBC reported in May that the company was hosting a summit the following month to pitch its platform as an alternative to traditional television and print media ads.

Source: https://www.cnbc.com/2017/09/07/facebook-held-a-breakfast-to-promote-clinical-trials-strategy.html

Advertisements

2 thoughts on “Facebook held a special breakfast for drug marketers about recruiting people for clinical trials

  1. While ostensibly this has many obvious benefits for patients, given Facebook’s tendency to become a clearinghouse for personal information it also has a lot of risks. Here they are facilitating conversations around Personal Health Information and Clinical Trials, two heavily regulated areas of industry. Meanwhile they were a platform for unregulated ads for Russian trolls and facilitated Russian information war while suggesting observations to the effect were “crazy”. Perhaps this shows why Facebook should get more regulatory scrutiny itself.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s